Chemoinformaics analysis of Nigakilactones B
| Molecular Weight | 392.492 | nRot | 2 |
| Heavy Atom Molecular Weight | 360.236 | nRig | 22 |
| Exact Molecular Weight | 392.22 | nRing | 4 |
| Solubility: LogS | -3.96 | nHRing | 1 |
| Solubility: LogP | 1.743 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 62.8894 |
| nHD | 1 | BPOL | 39.0466 |
| QED | 0.727 |
| Synth | 5.281 |
| Natural Product Likeliness | 3.459 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.998 |
| Pgp-sub | 0.032 |
| HIA | 0.046 |
| CACO-2 | -4.767 |
| MDCK | 0.0000319 |
| BBB | 0.975 |
| PPB | 0.799358 |
| VDSS | 0.862 |
| FU | 0.152405 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.436 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.917 |
| CYP2c9-inh | 0.017 |
| CYP2c9-sub | 0.07 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.236 |
| CYP3a4-inh | 0.453 |
| CYP3a4-sub | 0.61 |
| CL | 14.403 |
| T12 | 0.086 |
| hERG | 0.031 |
| Ames | 0.008 |
| ROA | 0.299 |
| SkinSen | 0.102 |
| Carcinogencity | 0.024 |
| EI | 0.007 |
| Respiratory | 0.482 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.534858 |